APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Coagulation Factor VIII

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Selected research

Market Analysis & Forecast

Global Human Coagulation Factor VIII Market Analysis and Forecast 2026-2032

9 January 2026199 pages

Choose your research edition.

Industry ResearchHuman Coagulation Factor VIII Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Coagulation Factor VIII Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Human Coagulation Factor VIII Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Coagulation Factor VIII Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Coagulation Factor VIII Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. Human Coagulation Factor VIII concentrated from donated blood plasma (Aafact or Alphanate, Monoclate-P®), or alternatively recombinant Human Coagulation Factor VIII can be given to hemophiliacs to restore hemostasis.

Global Human Coagulation Factor VIII key players include Baxter, Bayer, CSL, Pfizer, Biogen, etc. Global top five manufacturers hold a share about 80%. North America is the largest market, with a share about 60%, followed by Europe, with a share about 30 percent. In terms of product, Recombinant Factor VIII is the largest segment, with a share about 65%. And in terms of application, the largest application is Hemophilia A, followed by Spontanous / Trauma, Surgical, etc.

This report presents an overview of global market for Human Coagulation Factor VIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

Read the full market overview

This report researches the key producers of Human Coagulation Factor VIII, also provides the sales of main regions and countries. Of the upcoming market potential for Human Coagulation Factor VIII, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Coagulation Factor VIII sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Coagulation Factor VIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Coagulation Factor VIII sales, projected growth trends, production technology, application and end-user industry.

Human Coagulation Factor VIII Segment by Company

Shire (Baxter)

Bayer

CSL

Pfizer

Grifols

Biogen

Octapharma

NovoNordisk

Greencross

Kedrion

BPL

Hualan Bio

RAAS

Human Coagulation Factor VIII Segment by Type

Recombinant Factor VIII

Plasma-derived Factor VIII

Human Coagulation Factor VIII Segment by Application

Hemophilia A

Spontanous / Trauma

Surgical

Other

Human Coagulation Factor VIII Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Coagulation Factor VIII market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Coagulation Factor VIII and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Coagulation Factor VIII.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Coagulation Factor VIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Coagulation Factor VIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Coagulation Factor VIII sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Factor VIII Major Manufacturers Table 3. Plasma-derived Factor VIII Major Manufacturers Table 4. Global Human Coagulation Factor VIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hemophilia A Major Manufacturers Table 6. Spontanous / Trauma Major Manufacturers Table 7. Surgical Major Manufacturers Table 8. Other Major Manufacturers Table 9. Human Coagulation Factor VIII Industry Trends Table 10. Human Coagulation Factor VIII Industry Drivers Table 11. Human Coagulation Factor VIII Industry Opportunities and Challenges Table 12. Human Coagulation Factor VIII Industry Restraints Table 13. Global Human Coagulation Factor VIII Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Coagulation Factor VIII Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Coagulation Factor VIII Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Coagulation Factor VIII Revenue Market Share by Region (2021-2026) Table 17. Global Human Coagulation Factor VIII Revenue Market Share by Region (2027-2032) Table 18. Global Human Coagulation Factor VIII Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Bottles) Table 19. Global Human Coagulation Factor VIII Sales by Region (2021-2026) & (K Bottles) Table 20. Global Human Coagulation Factor VIII Sales by Region (2027-2032) & (K Bottles) Table 21. Global Human Coagulation Factor VIII Sales Market Share by Region (2021-2026) Table 22. Global Human Coagulation Factor VIII Sales Market Share by Region (2027-2032) Table 23. Global Human Coagulation Factor VIII Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Coagulation Factor VIII Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Coagulation Factor VIII Sales Price (USD/Bottle) of Manufacturers (2021-2026) Table 28. Global Human Coagulation Factor VIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Coagulation Factor VIII Manufacturers, Product Type & Application Table 31. Global Human Coagulation Factor VIII Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Coagulation Factor VIII by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Coagulation Factor VIII Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Coagulation Factor VIII Revenue Market Share by Type (2021-2026) Table 38. Global Human Coagulation Factor VIII Revenue Market Share by Type (2027-2032) Table 39. Global Human Coagulation Factor VIII Sales by Type 2021 VS 2025 VS 2032 (K Bottles) Table 40. Global Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 41. Global Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 42. Global Human Coagulation Factor VIII Sales Market Share by Type (2021-2026) Table 43. Global Human Coagulation Factor VIII Sales Market Share by Type (2027-2032) Table 44. Global Human Coagulation Factor VIII Price by Type (2021-2026) & (USD/Bottle) Table 45. Global Human Coagulation Factor VIII Price by Type (2027-2032) & (USD/Bottle) Table 46. Global Human Coagulation Factor VIII Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Coagulation Factor VIII Revenue Market Share by Application (2021-2026) Table 50. Global Human Coagulation Factor VIII Revenue Market Share by Application (2027-2032) Table 51. Global Human Coagulation Factor VIII Sales by Application 2021 VS 2025 VS 2032 (K Bottles) Table 52. Global Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 53. Global Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 54. Global Human Coagulation Factor VIII Sales Market Share by Application (2021-2026) Table 55. Global Human Coagulation Factor VIII Sales Market Share by Application (2027-2032) Table 56. Global Human Coagulation Factor VIII Price by Application (2021-2026) & (USD/Bottle) Table 57. Global Human Coagulation Factor VIII Price by Application (2027-2032) & (USD/Bottle) Table 58. Shire (Baxter) Company Information Table 59. Shire (Baxter) Business Overview Table 60. Shire (Baxter) Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 61. Shire (Baxter) Human Coagulation Factor VIII Product Portfolio Table 62. Shire (Baxter) Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 66. Bayer Human Coagulation Factor VIII Product Portfolio Table 67. Bayer Recent Development Table 68. CSL Company Information Table 69. CSL Business Overview Table 70. CSL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 71. CSL Human Coagulation Factor VIII Product Portfolio Table 72. CSL Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 76. Pfizer Human Coagulation Factor VIII Product Portfolio Table 77. Pfizer Recent Development Table 78. Grifols Company Information Table 79. Grifols Business Overview Table 80. Grifols Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 81. Grifols Human Coagulation Factor VIII Product Portfolio Table 82. Grifols Recent Development Table 83. Biogen Company Information Table 84. Biogen Business Overview Table 85. Biogen Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 86. Biogen Human Coagulation Factor VIII Product Portfolio Table 87. Biogen Recent Development Table 88. Octapharma Company Information Table 89. Octapharma Business Overview Table 90. Octapharma Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 91. Octapharma Human Coagulation Factor VIII Product Portfolio Table 92. Octapharma Recent Development Table 93. NovoNordisk Company Information Table 94. NovoNordisk Business Overview Table 95. NovoNordisk Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 96. NovoNordisk Human Coagulation Factor VIII Product Portfolio Table 97. NovoNordisk Recent Development Table 98. Greencross Company Information Table 99. Greencross Business Overview Table 100. Greencross Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 101. Greencross Human Coagulation Factor VIII Product Portfolio Table 102. Greencross Recent Development Table 103. Kedrion Company Information Table 104. Kedrion Business Overview Table 105. Kedrion Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 106. Kedrion Human Coagulation Factor VIII Product Portfolio Table 107. Kedrion Recent Development Table 108. BPL Company Information Table 109. BPL Business Overview Table 110. BPL Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 111. BPL Human Coagulation Factor VIII Product Portfolio Table 112. BPL Recent Development Table 113. Hualan Bio Company Information Table 114. Hualan Bio Business Overview Table 115. Hualan Bio Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 116. Hualan Bio Human Coagulation Factor VIII Product Portfolio Table 117. Hualan Bio Recent Development Table 118. RAAS Company Information Table 119. RAAS Business Overview Table 120. RAAS Human Coagulation Factor VIII Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2021-2026) Table 121. RAAS Human Coagulation Factor VIII Product Portfolio Table 122. RAAS Recent Development Table 123. North America Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 126. North America Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 127. North America Human Coagulation Factor VIII Sales Price by Type (2021-2026) & (USD/Bottle) Table 128. North America Human Coagulation Factor VIII Sales Price by Type (2027-2032) & (USD/Bottle) Table 129. North America Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 132. North America Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 133. North America Human Coagulation Factor VIII Sales Price by Application (2021-2026) & (USD/Bottle) Table 134. North America Human Coagulation Factor VIII Sales Price by Application (2027-2032) & (USD/Bottle) Table 135. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (K Bottles) Table 139. North America Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 140. North America Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 141. North America Human Coagulation Factor VIII Sales Price by Country (2021-2026) & (USD/Bottle) Table 142. North America Human Coagulation Factor VIII Sales Price by Country (2027-2032) & (USD/Bottle) Table 143. United States Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 144. Canada Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 145. Mexico Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 146. Europe Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 147. Europe Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 148. Europe Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 149. Europe Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 150. Europe Human Coagulation Factor VIII Sales Price by Type (2021-2026) & (USD/Bottle) Table 151. Europe Human Coagulation Factor VIII Sales Price by Type (2027-2032) & (USD/Bottle) Table 152. Europe Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 155. Europe Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 156. Europe Human Coagulation Factor VIII Sales Price by Application (2021-2026) & (USD/Bottle) Table 157. Europe Human Coagulation Factor VIII Sales Price by Application (2027-2032) & (USD/Bottle) Table 158. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Europe Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (K Bottles) Table 162. Europe Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 163. Europe Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 164. Europe Human Coagulation Factor VIII Sales Price by Country (2021-2026) & (USD/Bottle) Table 165. Europe Human Coagulation Factor VIII Sales Price by Country (2027-2032) & (USD/Bottle) Table 166. Germany Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 167. France Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 168. U.K. Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 169. Italy Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 170. Russia Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 171. Spain Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 172. Netherlands Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 173. Switzerland Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 174. Sweden Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 175. Poland Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 176. China Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 177. China Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 178. China Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 179. China Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 180. China Human Coagulation Factor VIII Sales Price by Type (2021-2026) & (USD/Bottle) Table 181. China Human Coagulation Factor VIII Sales Price by Type (2027-2032) & (USD/Bottle) Table 182. China Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 183. China Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 184. China Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 185. China Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 186. China Human Coagulation Factor VIII Sales Price by Application (2021-2026) & (USD/Bottle) Table 187. China Human Coagulation Factor VIII Sales Price by Application (2027-2032) & (USD/Bottle) Table 188. Asia Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 189. Asia Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 190. Asia Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 191. Asia Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 192. Asia Human Coagulation Factor VIII Sales Price by Type (2021-2026) & (USD/Bottle) Table 193. Asia Human Coagulation Factor VIII Sales Price by Type (2027-2032) & (USD/Bottle) Table 194. Asia Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 197. Asia Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 198. Asia Human Coagulation Factor VIII Sales Price by Application (2021-2026) & (USD/Bottle) Table 199. Asia Human Coagulation Factor VIII Sales Price by Application (2027-2032) & (USD/Bottle) Table 200. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. Asia Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (K Bottles) Table 204. Asia Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 205. Asia Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 206. Asia Human Coagulation Factor VIII Sales Price by Country (2021-2026) & (USD/Bottle) Table 207. Asia Human Coagulation Factor VIII Sales Price by Country (2027-2032) & (USD/Bottle) Table 208. Japan Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 209. South Korea Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 210. India Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 211. Australia Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 212. Taiwan Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 213. Southeast Asia Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 214. SAMEA Human Coagulation Factor VIII Revenue by Type (2021-2026) & (US$ Million) Table 215. SAMEA Human Coagulation Factor VIII Revenue by Type (2027-2032) & (US$ Million) Table 216. SAMEA Human Coagulation Factor VIII Sales by Type (2021-2026) & (K Bottles) Table 217. SAMEA Human Coagulation Factor VIII Sales by Type (2027-2032) & (K Bottles) Table 218. SAMEA Human Coagulation Factor VIII Sales Price by Type (2021-2026) & (USD/Bottle) Table 219. SAMEA Human Coagulation Factor VIII Sales Price by Type (2027-2032) & (USD/Bottle) Table 220. SAMEA Human Coagulation Factor VIII Revenue by Application (2021-2026) & (US$ Million) Table 221. SAMEA Human Coagulation Factor VIII Revenue by Application (2027-2032) & (US$ Million) Table 222. SAMEA Human Coagulation Factor VIII Sales by Application (2021-2026) & (K Bottles) Table 223. SAMEA Human Coagulation Factor VIII Sales by Application (2027-2032) & (K Bottles) Table 224. SAMEA Human Coagulation Factor VIII Sales Price by Application (2021-2026) & (USD/Bottle) Table 225. SAMEA Human Coagulation Factor VIII Sales Price by Application (2027-2032) & (USD/Bottle) Table 226. SAMEA Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 227. SAMEA Human Coagulation Factor VIII Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 228. SAMEA Human Coagulation Factor VIII Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 229. SAMEA Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032) & (K Bottles) Table 230. SAMEA Human Coagulation Factor VIII Sales by Country (2021-2026) & (K Bottles) Table 231. SAMEA Human Coagulation Factor VIII Sales by Country (2027-2032) & (K Bottles) Table 232. SAMEA Human Coagulation Factor VIII Sales Price by Country (2021-2026) & (USD/Bottle) Table 233. SAMEA Human Coagulation Factor VIII Sales Price by Country (2027-2032) & (USD/Bottle) Table 234. Brazil Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 235. Argentina Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 236. Chile Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 237. Colombia Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 238. Peru Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 239. Saudi Arabia Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 240. Israel Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 241. UAE Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 242. Turkey Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 243. Iran Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 244. Egypt Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Table 245. Key Raw Materials Table 246. Raw Materials Key Suppliers Table 247. Human Coagulation Factor VIII Distributors List Table 248. Human Coagulation Factor VIII Customers List Table 249. Research Programs/Design for This Report Table 250. Authors List of This Report Table 251. Secondary Sources Table 252. Primary Sources List of Figures Figure 1. Human Coagulation Factor VIII Image Figure 2. Global Human Coagulation Factor VIII Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Coagulation Factor VIII Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Factor VIII Image Figure 5. Plasma-derived Factor VIII Image Figure 6. Global Human Coagulation Factor VIII Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Coagulation Factor VIII Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hemophilia A Image Figure 9. Spontanous / Trauma Image Figure 10. Surgical Image Figure 11. Other Image Figure 12. Global Human Coagulation Factor VIII Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Coagulation Factor VIII Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Coagulation Factor VIII Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Coagulation Factor VIII Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Coagulation Factor VIII Revenue Market Share by Region (2021-2032) Figure 17. Global Human Coagulation Factor VIII Sales (2021-2032) & (K Bottles) Figure 18. Global Human Coagulation Factor VIII Sales by Region: 2021 VS 2025 VS 2032 (K Bottles) Figure 19. Global Human Coagulation Factor VIII Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Coagulation Factor VIII Sales YoY (2021-2032) & (K Bottles) Figure 21. Europe Human Coagulation Factor VIII Sales YoY (2021-2032) & (K Bottles) Figure 22. China Human Coagulation Factor VIII Sales YoY (2021-2032) & (K Bottles) Figure 23. Asia (Excluding China) Human Coagulation Factor VIII Sales YoY (2021-2032) & (K Bottles) Figure 24. South America, Middle East and Africa Human Coagulation Factor VIII Sales YoY (2021-2032) & (K Bottles) Figure 25. Global Human Coagulation Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Coagulation Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Coagulation Factor VIII Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Coagulation Factor VIII Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Coagulation Factor VIII Revenue Market Share by Type (2021-2032) Figure 31. Global Human Coagulation Factor VIII Sales by Type (2021 VS 2025 VS 2032) & (K Bottles) Figure 32. Global Human Coagulation Factor VIII Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Coagulation Factor VIII Sales Market Share by Type (2021-2032) Figure 34. Global Human Coagulation Factor VIII Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Coagulation Factor VIII Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Coagulation Factor VIII Revenue Market Share by Application (2021-2032) Figure 37. Global Human Coagulation Factor VIII Sales by Application (2021 VS 2025 VS 2032) & (K Bottles) Figure 38. Global Human Coagulation Factor VIII Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Coagulation Factor VIII Sales Market Share by Application (2021-2032) Figure 40. North America Human Coagulation Factor VIII Revenue Share by Type (2021-2032) Figure 41. North America Human Coagulation Factor VIII Sales Share by Type (2021-2032) Figure 42. North America Human Coagulation Factor VIII Revenue Share by Application (2021-2032) Figure 43. North America Human Coagulation Factor VIII Sales Share by Application (2021-2032) Figure 44. North America Human Coagulation Factor VIII Revenue Share by Country (2021-2032) Figure 45. North America Human Coagulation Factor VIII Sales Share by Country (2021-2032) Figure 46. Europe Human Coagulation Factor VIII Revenue Share by Type (2021-2032) Figure 47. Europe Human Coagulation Factor VIII Sales Share by Type (2021-2032) Figure 48. Europe Human Coagulation Factor VIII Revenue Share by Application (2021-2032) Figure 49. Europe Human Coagulation Factor VIII Sales Share by Application (2021-2032) Figure 50. Europe Human Coagulation Factor VIII Revenue Share by Country (2021-2032) Figure 51. Europe Human Coagulation Factor VIII Sales Share by Country (2021-2032) Figure 52. China Human Coagulation Factor VIII Revenue Share by Type (2021-2032) Figure 53. China Human Coagulation Factor VIII Sales Share by Type (2021-2032) Figure 54. China Human Coagulation Factor VIII Revenue Share by Application (2021-2032) Figure 55. China Human Coagulation Factor VIII Sales Share by Application (2021-2032) Figure 56. Asia Human Coagulation Factor VIII Revenue Share by Type (2021-2032) Figure 57. Asia Human Coagulation Factor VIII Sales Share by Type (2021-2032) Figure 58. Asia Human Coagulation Factor VIII Revenue Share by Application (2021-2032) Figure 59. Asia Human Coagulation Factor VIII Sales Share by Application (2021-2032) Figure 60. Asia Human Coagulation Factor VIII Revenue Share by Country (2021-2032) Figure 61. Asia Human Coagulation Factor VIII Sales Share by Country (2021-2032) Figure 62. SAMEA Human Coagulation Factor VIII Revenue Share by Type (2021-2032) Figure 63. SAMEA Human Coagulation Factor VIII Sales Share by Type (2021-2032) Figure 64. SAMEA Human Coagulation Factor VIII Revenue Share by Application (2021-2032) Figure 65. SAMEA Human Coagulation Factor VIII Sales Share by Application (2021-2032) Figure 66. SAMEA Human Coagulation Factor VIII Revenue Share by Country (2021-2032) Figure 67. SAMEA Human Coagulation Factor VIII Sales Share by Country (2021-2032) Figure 68. Human Coagulation Factor VIII Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Human Coagulation Factor VIII Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Factor VIII
  • Plasma-derived Factor VIII
Applications
  • Hemophilia A
  • Spontanous / Trauma
  • Surgical
  • Other
Companies covered
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Grifols
  • Biogen
  • Octapharma
  • NovoNordisk
  • Greencross
  • Kedrion
  • BPL
  • Hualan Bio
  • RAAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Coagulation Factor VIII Market by Type
  3. 1.2.1 Global Human Coagulation Factor VIII Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Factor VIII
  5. 1.2.3 Plasma-derived Factor VIII
  6. 1.3 Human Coagulation Factor VIII Market by Application
  7. 1.3.1 Global Human Coagulation Factor VIII Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hemophilia A
  9. 1.3.3 Spontanous / Trauma
  10. 1.3.4 Surgical
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Coagulation Factor VIII Market Dynamics
  1. 2.1 Human Coagulation Factor VIII Industry Trends
  2. 2.2 Human Coagulation Factor VIII Industry Drivers
  3. 2.3 Human Coagulation Factor VIII Industry Opportunities and Challenges
  4. 2.4 Human Coagulation Factor VIII Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Coagulation Factor VIII Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Coagulation Factor VIII Revenue by Region
  3. 3.2.1 Global Human Coagulation Factor VIII Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Coagulation Factor VIII Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Coagulation Factor VIII Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Coagulation Factor VIII Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Coagulation Factor VIII Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Coagulation Factor VIII Sales by Region
  9. 3.4.1 Global Human Coagulation Factor VIII Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Coagulation Factor VIII Sales by Region (2021-2026)
  11. 3.4.3 Global Human Coagulation Factor VIII Sales by Region (2027-2032)
  12. 3.4.4 Global Human Coagulation Factor VIII Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Coagulation Factor VIII Revenue by Manufacturers
  2. 4.1.1 Global Human Coagulation Factor VIII Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Coagulation Factor VIII Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Coagulation Factor VIII Sales by Manufacturers
  6. 4.2.1 Global Human Coagulation Factor VIII Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Coagulation Factor VIII Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Coagulation Factor VIII Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Coagulation Factor VIII Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Coagulation Factor VIII Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Coagulation Factor VIII Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Coagulation Factor VIII Manufacturers, Product Type & Application
  13. 4.7 Global Human Coagulation Factor VIII Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Coagulation Factor VIII Market CR5 and HHI
  16. 4.8.2 2025 Human Coagulation Factor VIII Tier 1, Tier 2, and Tier 3
5 Human Coagulation Factor VIII Market by Type
  1. 5.1 Global Human Coagulation Factor VIII Revenue by Type
  2. 5.1.1 Global Human Coagulation Factor VIII Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Coagulation Factor VIII Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Coagulation Factor VIII Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Coagulation Factor VIII Sales by Type
  6. 5.2.1 Global Human Coagulation Factor VIII Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Coagulation Factor VIII Sales by Type (2021-2032) & (K Bottles)
  8. 5.2.3 Global Human Coagulation Factor VIII Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Coagulation Factor VIII Price by Type
6 Human Coagulation Factor VIII Market by Application
  1. 6.1 Global Human Coagulation Factor VIII Revenue by Application
  2. 6.1.1 Global Human Coagulation Factor VIII Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Coagulation Factor VIII Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Coagulation Factor VIII Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Coagulation Factor VIII Sales by Application
  6. 6.2.1 Global Human Coagulation Factor VIII Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Coagulation Factor VIII Sales by Application (2021-2032) & (K Bottles)
  8. 6.2.3 Global Human Coagulation Factor VIII Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Coagulation Factor VIII Price by Application
7 Company Profiles
  1. 7.1 Shire (Baxter)
  2. 7.1.1 Shire (Baxter) Company Information
  3. 7.1.2 Shire (Baxter) Business Overview
  4. 7.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Shire (Baxter) Human Coagulation Factor VIII Product Portfolio
  6. 7.1.5 Shire (Baxter) Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Human Coagulation Factor VIII Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 CSL
  14. 7.3.1 CSL Company Information
  15. 7.3.2 CSL Business Overview
  16. 7.3.3 CSL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Human Coagulation Factor VIII Product Portfolio
  18. 7.3.5 CSL Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Human Coagulation Factor VIII Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 Grifols
  26. 7.5.1 Grifols Company Information
  27. 7.5.2 Grifols Business Overview
  28. 7.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Grifols Human Coagulation Factor VIII Product Portfolio
  30. 7.5.5 Grifols Recent Developments
  31. 7.6 Biogen
  32. 7.6.1 Biogen Company Information
  33. 7.6.2 Biogen Business Overview
  34. 7.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Biogen Human Coagulation Factor VIII Product Portfolio
  36. 7.6.5 Biogen Recent Developments
  37. 7.7 Octapharma
  38. 7.7.1 Octapharma Company Information
  39. 7.7.2 Octapharma Business Overview
  40. 7.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Octapharma Human Coagulation Factor VIII Product Portfolio
  42. 7.7.5 Octapharma Recent Developments
  43. 7.8 NovoNordisk
  44. 7.8.1 NovoNordisk Company Information
  45. 7.8.2 NovoNordisk Business Overview
  46. 7.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 NovoNordisk Human Coagulation Factor VIII Product Portfolio
  48. 7.8.5 NovoNordisk Recent Developments
  49. 7.9 Greencross
  50. 7.9.1 Greencross Company Information
  51. 7.9.2 Greencross Business Overview
  52. 7.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Greencross Human Coagulation Factor VIII Product Portfolio
  54. 7.9.5 Greencross Recent Developments
  55. 7.10 Kedrion
  56. 7.10.1 Kedrion Company Information
  57. 7.10.2 Kedrion Business Overview
  58. 7.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Kedrion Human Coagulation Factor VIII Product Portfolio
  60. 7.10.5 Kedrion Recent Developments
  61. 7.11 BPL
  62. 7.11.1 BPL Company Information
  63. 7.11.2 BPL Business Overview
  64. 7.11.3 BPL Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 BPL Human Coagulation Factor VIII Product Portfolio
  66. 7.11.5 BPL Recent Developments
  67. 7.12 Hualan Bio
  68. 7.12.1 Hualan Bio Company Information
  69. 7.12.2 Hualan Bio Business Overview
  70. 7.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hualan Bio Human Coagulation Factor VIII Product Portfolio
  72. 7.12.5 Hualan Bio Recent Developments
  73. 7.13 RAAS
  74. 7.13.1 RAAS Company Information
  75. 7.13.2 RAAS Business Overview
  76. 7.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 RAAS Human Coagulation Factor VIII Product Portfolio
  78. 7.13.5 RAAS Recent Developments
8 North America
  1. 8.1 North America Human Coagulation Factor VIII Market Size by Type
  2. 8.1.1 North America Human Coagulation Factor VIII Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Coagulation Factor VIII Sales by Type (2021-2032)
  4. 8.1.3 North America Human Coagulation Factor VIII Price by Type (2021-2032)
  5. 8.2 North America Human Coagulation Factor VIII Market Size by Application
  6. 8.2.1 North America Human Coagulation Factor VIII Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Coagulation Factor VIII Sales by Application (2021-2032)
  8. 8.2.3 North America Human Coagulation Factor VIII Price by Application (2021-2032)
  9. 8.3 North America Human Coagulation Factor VIII Market Size by Country
  10. 8.3.1 North America Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Coagulation Factor VIII Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Coagulation Factor VIII Market Size by Type
  2. 9.1.1 Europe Human Coagulation Factor VIII Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Coagulation Factor VIII Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Coagulation Factor VIII Price by Type (2021-2032)
  5. 9.2 Europe Human Coagulation Factor VIII Market Size by Application
  6. 9.2.1 Europe Human Coagulation Factor VIII Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Coagulation Factor VIII Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Coagulation Factor VIII Price by Application (2021-2032)
  9. 9.3 Europe Human Coagulation Factor VIII Market Size by Country
  10. 9.3.1 Europe Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Coagulation Factor VIII Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Coagulation Factor VIII Market Size by Type
  2. 10.1.1 China Human Coagulation Factor VIII Revenue by Type (2021-2032)
  3. 10.1.2 China Human Coagulation Factor VIII Sales by Type (2021-2032)
  4. 10.1.3 China Human Coagulation Factor VIII Price by Type (2021-2032)
  5. 10.2 China Human Coagulation Factor VIII Market Size by Application
  6. 10.2.1 China Human Coagulation Factor VIII Revenue by Application (2021-2032)
  7. 10.2.2 China Human Coagulation Factor VIII Sales by Application (2021-2032)
  8. 10.2.3 China Human Coagulation Factor VIII Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Coagulation Factor VIII Market Size by Type
  2. 11.1.1 Asia Human Coagulation Factor VIII Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Coagulation Factor VIII Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Coagulation Factor VIII Price by Type (2021-2032)
  5. 11.2 Asia Human Coagulation Factor VIII Market Size by Application
  6. 11.2.1 Asia Human Coagulation Factor VIII Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Coagulation Factor VIII Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Coagulation Factor VIII Price by Application (2021-2032)
  9. 11.3 Asia Human Coagulation Factor VIII Market Size by Country
  10. 11.3.1 Asia Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Coagulation Factor VIII Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Coagulation Factor VIII Market Size by Type
  2. 12.1.1 SAMEA Human Coagulation Factor VIII Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Coagulation Factor VIII Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Coagulation Factor VIII Price by Type (2021-2032)
  5. 12.2 SAMEA Human Coagulation Factor VIII Market Size by Application
  6. 12.2.1 SAMEA Human Coagulation Factor VIII Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Coagulation Factor VIII Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Coagulation Factor VIII Price by Application (2021-2032)
  9. 12.3 SAMEA Human Coagulation Factor VIII Market Size by Country
  10. 12.3.1 SAMEA Human Coagulation Factor VIII Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Coagulation Factor VIII Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Coagulation Factor VIII Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Coagulation Factor VIII Value Chain Analysis
  2. 13.1.1 Human Coagulation Factor VIII Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Coagulation Factor VIII Production Mode & Process
  6. 13.2 Human Coagulation Factor VIII Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Coagulation Factor VIII Distributors
  9. 13.2.3 Human Coagulation Factor VIII Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst